Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo
Jd. Reeves et al., Primary human immunodeficiency virus type 2 (HIV-2) isolates infect CD4-negative cells via CCR5 and CXCR4: Comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo, J VIROLOGY, 73(9), 1999, pp. 7795-7804
Cell surface receptors exploited by human immunodeficiency virus (HIV) and
simian immunodeficiency virus (SIV) for infection are major determinants of
tropism. HIV-1 usually requires two receptors to infect cells. Gp120 on HI
V-1 virions binds CD4 on the cell surface, triggering conformational rearra
ngements that create or expose a binding site for a seven-transmembrane (7T
M) coreceptor. Although HIV-2 and SIV strains also use CD4, several laborat
ory-adapted HIV-2 strains infect cells without CD4, via an interaction with
the coreceptor CXCR4. Moreover, the envelope glycoproteins of SIV of macaq
ues (SIVMAC) can bind to and initiate infection of CD4(-) cells via CCR5. H
ere, we show that most primary HIV-2 isolates can infect either CCR5(+) or
CXCR4(+) cells without CD4. The efficiency of CD4-independent infection by
HIV-2 was comparable to that of SIV, but markedly higher than that of HIV-1
. CD4(-)independent HIV-2 strains that could use both CCR5 and CXCR4 to inf
ect CD4(+) cells were only able to use one of these receptors in the absenc
e of CD4. Our observations therefore indicate (i) that HIV-2 and SIV envelo
pe glycoproteins form a distinct conformation that enables contact with a 7
TM receptor without CD4, and (ii) the use of CD4 enables a wider range of 7
TM receptors to be exploited for infection and may assist adaptation or swi
tching to new coreceptors in vivo. Primary CD4(-) fetal astrocyte cultures
expressed CXCR4 and supported replication by the T-cell-line-adapted ROD/B
strain. Productive infection by primary X4 strains was only triggered upon
treatment of virus with soluble CD4. Thus, many primary HIV-2 strains infec
t CCR5(+) or CXCR4(+) cell lines without CD4 in vitro. CD4(-) cells that ex
press these coreceptors in vivo, however, may still resist HIV-2 entry due
to insufficient coreceptor concentration on the cell surface to trigger fus
ion or their expression in a conformation nonfunctional as a coreceptor. Ou
r study, however, emphasizes that primary HIV-2 strains carry the potential
to infect CD4(-) cells expressing CCR5 or CXCR4 in vivo.